Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Antiviral treatment for COVID-19: the evidence supporting remdesivir

Charlotte Richardson, Sanjay Bhagani and Gabriele Pollara
Download PDF
DOI: https://doi.org/10.7861/clinmed.2020-0524
Clin Med November 2020
Charlotte Richardson
ARoyal Free London NHS Foundation Trust
Roles: specialist registrar in infectious diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: charlotterichardson1@nhs.net
Sanjay Bhagani
BRoyal Free London NHS Foundation Trust, and honorary senior lecturer, University College London
Roles: consultant physician in infectious diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriele Pollara
CRoyal Free London NHS Foundation Trust, and Wellcome Trust postdoctoral clinical research fellow and NIHR clinical lecturer, University College London
Roles: specialist registrar in infectious diseases
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Figures & Data

Tables

    • View popup
    Box 1.

    NHS interim clinical commissioning policy: Remdesivir for patients hospitalised with COVID-19 (adults and children aged 12 years and older)13

    Eligibility criteria (in accordance with the product licence):
    • Hospitalised with COVID-19

    • With pneumonia requiring supplemental oxygen

    • Adults, and adolescents ≥12 years of age and ≥40 kg

    • eGFR ≥30 ml/min

    • Alanine aminotransferase (ALT) below 5 times the upper limit of normal at baseline

    Remdesivir should be avoided in pregnancy unless clinicians believe the benefits of treatment outweigh the risks to the individual.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Antiviral treatment for COVID-19: the evidence supporting remdesivir
Charlotte Richardson, Sanjay Bhagani, Gabriele Pollara
Clinical Medicine Nov 2020, 20 (6) e215-e217; DOI: 10.7861/clinmed.2020-0524

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Antiviral treatment for COVID-19: the evidence supporting remdesivir
Charlotte Richardson, Sanjay Bhagani, Gabriele Pollara
Clinical Medicine Nov 2020, 20 (6) e215-e217; DOI: 10.7861/clinmed.2020-0524
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ABSTRACT
    • Key messages
    • Introduction
    • Clinical trials
    • Clinical context
    • Future research and conclusions
    • References
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Real-world use of the Breathing Pattern Assessment Tool in assessment of breathlessness post-COVID-19
  • Understanding the diagnosis and management of multisystem inflammatory syndrome in adults (MIS-A) in the UK: results of a national Delphi process
  • The clinical course of pneumomediastinum in patients with SARS-CoV-2 before invasive mechanical ventilation
Show more COVID-19 rapid report

Similar Articles

FAQs

  • Difficulty logging in.

There is currently no login required to access the journals. Please go to the home page and simply click on the edition that you wish to read. If you are still unable to access the content you require, please let us know through the 'Contact us' page.

  • Can't find the CME questionnaire.

The read-only self-assessment questionnaire (SAQ) can be found after the CME section in each edition of Clinical Medicine. RCP members and fellows (using their login details for the main RCP website) are able to access the full SAQ with answers and are awarded 2 CPD points upon successful (8/10) completion from:  https://cme.rcplondon.ac.uk

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2023 by the Royal College of Physicians